💊 Rahika (Capmatinib 150 mg Tablets)
Rahika (Capmatinib 150 mg Tablets) is a targeted anti-cancer medicine used in the treatment of Non-Small Cell Lung Cancer (NSCLC) with specific genetic mutations (MET exon 14 skipping).
Capmatinib belongs to a class of drugs called MET inhibitors, which work by blocking abnormal signals that promote cancer cell growth, helping to slow down or stop tumor progression.
💊 How to Use
-
Take Rahika tablets exactly as prescribed by your oncologist
-
Usually taken orally with or without food
-
Swallow whole with water (do not crush or chew)
-
Take doses at the same time each day for best results
-
Do not skip doses; if missed, follow your doctor’s advice
🩺 Uses / Indications
Rahika (Capmatinib 150 mg Tablets) is used for:
-
Treatment of advanced or metastatic NSCLC
-
Patients with MET exon 14 skipping mutation
-
Targeted therapy when traditional chemotherapy is less effective
💉 Dosage
-
Typical adult dose: 400 mg twice daily (as directed by doctor)
-
Dosage may vary based on:
Side effects
Response to treatment
Patient condition
-
Always follow medical supervision strictly
✅ Advantages
-
✔️ Targeted therapy with higher precision
-
✔️ Effective for genetically identified lung cancer cases
-
✔️ Helps slow disease progression
-
✔️ Oral tablet form – convenient administration
-
✔️ Improved patient outcomes compared to traditional chemotherapy
🏥 Treatment Benefits
-
Personalized cancer treatment approach
-
Reduces tumor growth and spread
-
Enhances quality of life in advanced cancer patients
-
Suitable for long-term management under supervision
📦 Storage Conditions
-
Store at room temperature (20°C–25°C)
-
Keep in a dry place away from moisture
-
Protect from direct sunlight
-
Keep out of reach of children
-
Store in original packaging
🇮🇳 Alternative Indian Brands of Capmatinib
Some alternative brands available include:
-
Tabrecta (Capmatinib Tablets) – by Novartis
-
Capmatinib Tablets (generic versions) – by leading Indian pharma companies such as:
Dr. Reddy's Laboratories
Natco Pharma
(Availability depends on export regulations and country approvals.)
🌍 Why Choose GlobMedIndia?
GlobMedIndia – The Medicines Exporter ensures:
-
✔️ Genuine WHO-GMP certified medicines
-
✔️ Affordable pricing for global patients
-
✔️ Secure packaging & temperature-controlled shipping
-
✔️ Fast delivery to South Africa & neighboring countries
-
✔️ Complete export documentation support
🚚 Delivery Coverage (Africa Focus)
We provide fast and safe delivery to:
-
South Africa
-
Botswana
-
Lesotho
-
Mozambique
-
Namibia
-
Eswatini
-
Zimbabwe
Buy Rahika Capmatinib 150 mg Tablets Online – GlobMedIndia Exporter
Order Rahika (Capmatinib 150 mg Tablets) online from GlobMedIndia. Trusted exporter of anti-cancer medicines with fast delivery to South Africa, Botswana, Namibia, Zimbabwe, and across Africa.
Looking to buy Rahika (Capmatinib 150 mg Tablets) online at the best price? GlobMedIndia is a leading exporter of targeted oncology medicines from India. Capmatinib is an advanced therapy used in treating non-small cell lung cancer with MET mutations.
We ensure safe packaging, genuine products, and fast doorstep delivery to South Africa, Botswana, Lesotho, Mozambique, Namibia, and Zimbabwe. With our global supply network, patients receive high-quality medicines at affordable prices.
Choose GlobMedIndia for reliable service, expert support, and timely delivery of life-saving cancer treatments.
Rahika Capmatinib 150 mg Tablets
-
Capmatinib tablets India
-
Buy Capmatinib online
-
Capmatinib NSCLC treatment
-
Capmatinib tablets exporter India
Capmatinib South Africa supplier
-
Buy Capmatinib Botswana Namibia Zimbabwe
-
Capmatinib tablets Africa delivery
-
Oncology medicines exporter Africa
Buy Rahika Capmatinib 150 mg tablets online India
-
Capmatinib tablets for lung cancer treatment
-
Affordable targeted therapy NSCLC India
-
Capmatinib tablets fast delivery Africa
-
MET exon 14 skipping mutation treatment
Order Capmatinib tablets online
-
Capmatinib tablets wholesale supplier
-
Anti cancer medicines exporter India
-
Oncology drug supplier GlobMedIndia
📌 Conclusion
Rahika (Capmatinib 150 mg Tablets) is a highly effective targeted therapy for patients with advanced non-small cell lung cancer driven by MET mutations. Its precision mechanism and oral administration make it a preferred choice in modern oncology treatment.
With GlobMedIndia, patients across Africa can access genuine, affordable, and life-saving medicines with fast and secure delivery right to their doorstep.
